Boston Scientific Likely To Post Strong Growth In Q1’16, Driven by Cardiovascular Segment
Boston Scientific (NYSE:BSX) will release its first quarter earnings release in coming days, though it has yet to schedule the event. In the tables below, we review the consensus numbers and what we expect from the individual segments:
Notes:
See More at Trefis | View Interactive Institutional Research (Powered by Trefis)
- Should You Pick Boston Scientific Stock After A Solid Q4 And 13% Uptick This Year?
- What’s Next For Boston Scientific Stock After 5% Gains In A Week?
- Should You Pick MGM Resorts Over Boston Scientific Stock For Better Returns?
- Which Is A Better Buy – Boston Scientific Stock Or Abbott?
- What’s Next For Boston Scientific Stock After Outperforming During The 2022 Inflation Shock?
- New Product Launches To Aid Boston Scientific’s Q1